Renaissance Technologies (RenTech)'s CRMD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 54,577 shares of CorMedix Inc. (CRMD) worth $420,243, representing 0.00% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in CRMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 152,200 shares. Largest reduction occurred in Q2 2023, reducing 181,724 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s CorMedix (CRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CorMedix (CRMD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +54,577 | New Buy | 54,577 | $7.70 |
| Q3 2025 | -152,200 | Sold Out | 0 | $0.00 |
| Q2 2025 | +152,200 | New Buy | 152,200 | $12.32 |
| Q1 2025 | -134,000 | Sold Out | 0 | $0.00 |
| Q4 2024 | +134,000 | New Buy | 134,000 | $8.10 |
| Q3 2024 | -160,734 | Sold Out | 0 | $0.00 |
| Q2 2024 | -77,925 | Reduce 32.65% | 160,734 | $4.33 |
| Q1 2024 | +2,959 | Add 1.26% | 238,659 | $4.24 |
| Q4 2023 | +129,100 | Add 121.11% | 235,700 | $3.76 |
| Q3 2023 | +106,600 | New Buy | 106,600 | $3.70 |
| Q2 2023 | -181,724 | Sold Out | 0 | $0.00 |
| Q1 2023 | +108,124 | Add 146.91% | 181,724 | $0.00 |
| Q4 2022 | +60,000 | Add 441.18% | 73,600 | $0.00 |
| Q3 2022 | +13,600 | New Buy | 13,600 | $2.79 |
| Q2 2022 | -10,157 | Sold Out | 0 | $0.00 |
| Q1 2022 | +10,157 | New Buy | 10,157 | $5.51 |
| Q4 2021 | -118,001 | Sold Out | 0 | $0.00 |
| Q3 2021 | +118,001 | New Buy | 118,001 | $4.65 |
| Q1 2021 | -43,700 | Sold Out | 0 | $0.00 |
| Q4 2020 | +43,700 | New Buy | 43,700 | $7.44 |
| Q2 2020 | -128,900 | Sold Out | 0 | $0.00 |
| Q1 2020 | +72,500 | Add 128.55% | 128,900 | $3.59 |
| Q4 2019 | +56,400 | New Buy | 56,400 | $7.29 |
Renaissance Technologies (RenTech)'s CorMedix Investment FAQs
Renaissance Technologies (RenTech) first purchased CorMedix Inc. (CRMD) in Q4 2019, acquiring 56,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held CorMedix Inc. (CRMD) for 23 quarters since Q4 2019.
Renaissance Technologies (RenTech)'s largest addition to CorMedix Inc. (CRMD) was in Q2 2025, adding 152,200 shares worth $1.88 M.
According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 54,577 shares of CorMedix Inc. (CRMD), valued at approximately $420,243.
As of the Q3 2026 filing, CorMedix Inc. (CRMD) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in CorMedix Inc. (CRMD) was 238,659 shares, as reported at the end of Q1 2024.